Ezetimibe/rosuvastatin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ezetimibe/rosuvastatin
F
- FaLessa Kit (ethinyl estradiol / folic acid / levonorgestrel)
- Fallback Solo (levonorgestrel)
- Falmina (ethinyl estradiol / levonorgestrel)
- Fasigyn (tinidazole)
- Fast Acting Mylanta (calcium carbonate / magnesium hydroxide)
- Fayosim (ethinyl estradiol / levonorgestrel)
- febuxostat
- Femcon Fe (ethinyl estradiol / norethindrone)
- femhrt (ethinyl estradiol / norethindrone)
- Femlyv (ethinyl estradiol / norethindrone)
- Femynor (ethinyl estradiol / norgestimate)
- fenofibrate
- fenofibric acid
- Fenoglide (fenofibrate)
- fexinidazole
- Fibricor (fenofibric acid)
- Finzala (ethinyl estradiol / norethindrone)
- FIRST Mouthwash BLM (aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical)
- Flagyl (metronidazole)
- Flagyl 375 (metronidazole)
- Flagyl ER (metronidazole)
- Flagyl IV (metronidazole)
- Flanax Antacid Liquid (aluminum hydroxide / magnesium hydroxide / simethicone)
- flax
- Flax Seed Oil (flax)
- FloLipid (simvastatin)
- Florical (calcium carbonate / fluoride)
- fluconazole
- Fludara (fludarabine)
- fludarabine
- fluvastatin
- Folex PFS (methotrexate)
- Fortovase (saquinavir)
- fostamatinib
- fostemsavir
- Fotivda (tivozanib)
- Furadantin (nitrofurantoin)
- futibatinib
- Fyavolv (ethinyl estradiol / norethindrone)
More about ezetimibe / rosuvastatin
- ezetimibe/rosuvastatin consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antihyperlipidemic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.